National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Key Points

• National Research shares crossed above their 200-day moving average, reaching $21.56 and last trading at $21.19, compared with a 200-day average of $19.69.
• Analysts have a consensus “Moderate Buy” rating and a $26.00 price target, while recent ratings included one Buy and one Hold.
• The company exceeded quarterly expectations, reporting $0.31 EPS and $35.39 million in revenue, and declared a quarterly dividend of $0.16 per share, equivalent to a 3.0% annual yield.

National Research Corporation (NASDAQ:NRC - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $19.69 and traded as high as $21.56. National Research shares last traded at $21.19, with a volume of 142,651 shares traded.

Wall Street Analyst Weigh In

NRC has been the subject of several research reports. Weiss Ratings raised National Research from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, August 21st. Citizens Jmp upped their price target on National Research from $23.00 to $26.00 and gave the company a "market outperform" rating in a research note on Wednesday, July 29th. Finally, Wall Street Zen cut National Research from a "buy" rating to a "hold" rating in a report on Saturday, August 15th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $26.00.

National Research Stock Up 0.7%

The company has a debt-to-equity ratio of 13.13, a current ratio of 0.65 and a quick ratio of 0.65. The stock has a market cap of $482.07 million, a price-to-earnings ratio of 84.76 and a beta of 0.35. The firm has a 50 day simple moving average of $21.01 and a two-hundred day simple moving average of $19.69.

National Research (NASDAQ:NRC - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.46. The company had revenue of $35.39 million during the quarter, compared to analyst estimates of $34.90 million. National Research had a return on equity of 164.26% and a net margin of 4.18%.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Investors of record on Friday, September 25th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 25th. This represents a $0.64 dividend on an annualized basis and a yield of 3.0%. National Research's payout ratio is currently 256.00%.

Institutional Investors Weigh In On National Research

Several large investors have recently bought and sold shares of NRC. Empirical Finance LLC acquired a new stake in National Research in the 2nd quarter valued at approximately $431,000. Empowered Funds LLC bought a new stake in National Research in the 1st quarter valued at approximately $226,000. Bank of America Corp DE boosted its position in National Research by 3.0% during the 1st quarter. Bank of America Corp DE now owns 112,468 shares of the company's stock worth $1,910,000 after acquiring an additional 3,323 shares during the last quarter. Quantinno Capital Management LP boosted its position in National Research by 61.3% during the 1st quarter. Quantinno Capital Management LP now owns 62,329 shares of the company's stock worth $1,058,000 after acquiring an additional 23,682 shares during the last quarter. Finally, Heartland Advisors Inc. grew its stake in shares of National Research by 374.3% during the 1st quarter. Heartland Advisors Inc. now owns 237,147 shares of the company's stock worth $4,027,000 after acquiring an additional 187,147 shares in the last quarter. Institutional investors own 47.26% of the company's stock.

About National Research

National Research Corporation, doing business as NRC Health, provides research, analytics and technology solutions to the health care industry. The company helps hospitals, health systems and other care organizations understand patient and consumer perceptions, improve the care experience and strengthen relationships with the communities they serve.

Its offerings include patient and employee experience measurement, market and consumer insights, reputation management, customer relationship tools and analytics designed to support service improvement and strategic decision-making.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.